Autologous bone marrow ex vivo loaded with unarmed-MYXV or TNF-armed MYXV delays the onset of MM disease in vivo and improves survival rates in mice pre-seeded with BOR-resistant murine Vk12598 myeloma cells. The gene discussed is TNF; the disease is Miyoshi myopathy.